Targeting proprotein convertase subtilisin/kexin type 7 in macrophages as a therapeutic strategy to mitigate myocardial infarction-induced inflammation
Shin Hye Moon, Inyoung Chung, Na Hyeon Yoon, Jing Jin, Hyae Yon Kweon, Won Kee Yoon, Nabil G Seidah, Goo Taeg Oh · 2024
Read Targeting proprotein convertase subtilisin/kexin type 7 in macrophages as a therapeutic strategy to mitigate myocardial infarction-induced inflammation by Shin Hye Moon, Inyoung Chung, Na Hyeon Yoon, Jing Jin, Hyae Yon Kweon, Won Kee Yoon, Nabil G Seidah, Goo Taeg Oh (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11693601.txt.
Description
Shin Moon and colleagues target an enzyme in immune cells to calm heart attack inflammation. Their study from twenty twenty-four examines PCSK7 in macrophages. Heart attacks trigger fierce inflammation that kills more heart tissue. That response also drives harmful reshaping of the heart later.
Mice lacking PCSK7 carried lower blood cholesterol levels. Their heart injury after infarction was milder in the experiments. Normal PCSK7 pushed macrophages to activate and swallow more lipid. Those actions worsened damage at the oxygen-starved site. Blocking the enzyme therefore looks like a plausible treatment route. The study links a little-known enzyme to both lipids and cardiac immunity.
Catalog record
| CREATOR | Shin Hye Moon, Inyoung Chung, Na Hyeon Yoon, Jing Jin, Hyae Yon Kweon, Won Kee Yoon, Nabil G Seidah, Goo Taeg Oh |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |